Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure

被引:4
|
作者
Luermans, Justin G. L. M. [1 ]
Bos, Willem J. W. [2 ]
Post, Martijn C. [1 ]
ten Berg, Jurrien M. [1 ]
Plokker, H. W. Thijs [1 ]
Suttorp, Maarten J. [1 ]
机构
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Internal Med, NL-3435 CM Nieuwegein, Netherlands
关键词
atrial septal defect; Finometer; haemodynamics; patent foramen ovale; transcatheter closure; TRANSCATHETER CLOSURE; ARTERIAL-PRESSURE; FINGER; HUMANS; FLOW;
D O I
10.1111/j.1475-097X.2009.00905.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
P>Objectives: We investigated the haemodynamic effect of percutaneous closure of an intra-atrial shunt, using non-invasive finger pressure measurements. Background: Percutaneous closure of both patent foramen ovale (PFO) and atrial septal defect (ASD) is widely practised. Currently no data are available on short-term haemodynamic changes induced by closure. Methods: Twenty-five consecutive patients (mean age 49 +/- 17 years, 10 men) who underwent a percutaneous closure of a PFO (n = 15) or ASD (n = 10) were included in this study. During the procedure blood pressure and heart rate (HR) were monitored continuously with a Finometer (R). Changes in systolic, mean, and diastolic pressure, stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were computed from the pressure registrations using Modelflow (R) methodology. Results: Baseline characteristics were similar for the PFO and ASD patients. After PFO closure none of the haemodynamic parameters changed significantly. After ASD closure the systolic, mean, and diastolic pressures increased 7 center dot 1 +/- 5 center dot 4 (P = 0 center dot 003), 3 center dot 8 +/- 3 center dot 5 (P = 0 center dot 007) and 2 center dot 0 +/- 3 center dot 0 mmHg (P = ns) respectively. HR decreased 5 center dot 1 +/- 5 center dot 3 beats per minute (P = 0 center dot 01). SV, CO and TPR increased 8 center dot 5 +/- 6 center dot 4 ml (13 center dot 5%; P = 0 center dot 002), 0 center dot 21 +/- 0 center dot 45 l min-1 (5 center dot 6%; P = ns) and 0 center dot 02 +/- 0 center dot 14 dynes (4 center dot 1%; P = ns) respectively. The changes in SV differ between the PFO and ASD patients (P = 0 center dot 009). Conclusions: Using non-invasive finger pressure measurements, we found that SV, mean and systolic blood pressure increased immediately after percutaneous closure of an ASD in adults, whereas the percutaneous PFO closure had no effect on haemodynamic characteristics.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [21] Percutaneous closure of Patent Foramen Ovale (PFO) and atrial septal defect (ASD): A single centre experience and results
    Egred, M.
    Andron, M.
    Albouaini, K.
    Alahmar, A.
    Grainger, R.
    Grayson, A.
    Morrison, W. L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 803 - 804
  • [22] Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004
    Opotowsky, Alexander R.
    Landzberg, Michael J.
    Kimmel, Stephen E.
    Webb, Gary D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (05): : 521 - 522
  • [23] Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale
    Earing, MG
    Cabalka, AK
    Seward, JB
    Bruce, CJ
    Reeder, GS
    Hagler, DJ
    MAYO CLINIC PROCEEDINGS, 2004, 79 (01) : 24 - 34
  • [24] Percutaneous patent foramen ovale closure
    Carroll, JD
    Dodge, S
    Groves, BM
    CARDIOLOGY CLINICS, 2005, 23 (01) : 13 - +
  • [25] Percutaneous closure of patent foramen ovale
    Kleber, Franz Xaver
    Stretz, Anna
    SWISS MEDICAL WEEKLY, 2008, 138 (39-40) : 564 - 566
  • [26] Percutaneous closure of patent foramen ovale
    Bijl, JM
    Ruygrok, PN
    Hornung, TS
    Wilson, NJ
    West, T
    INTERNAL MEDICINE JOURNAL, 2005, 35 (12) : 706 - 710
  • [27] Percutaneous closure of patent foramen ovale
    Schieffer, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (14) : 770 - 770
  • [28] Comparison of residual shunt and complication rate between the amplatzer and cardioseal devices for patent foramen ovale/atrial septal defect closure.
    Giesler, G
    Muench, A
    Boccalandro, F
    Butkevich, A
    Carter, C
    Smalling, RW
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 169E - 169E
  • [29] Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale
    Susuri, Njomeza
    Obeid, Slayman
    Ulmi, Mirjam
    Siontis, George C. M.
    Wahl, Andreas
    Windecker, Stephan
    Nietlispach, Fabian
    Meier, Bernhard
    Praz, Fabien
    EUROINTERVENTION, 2017, 13 (07) : 858 - 866
  • [30] Percutaneous Closure of Patent Foramen Ovale and the Risk of Atrial Fibrillation
    Bhindi, Ravinay
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (02) : 301 - 301